Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06SEA
|
||||
| Former ID |
DIB000190
|
||||
| Drug Name |
CX-7000
|
||||
| Synonyms |
Second generation CK2 inhibitors (cancer), Cylene
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543439] | ||
| Company |
Cylene Pharmaceuticals Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Casein kinase II, alpha chain | Target Info | Inhibitor | [543439] | |
| NetPath Pathway | FSH Signaling Pathway | ||||
| Pathway Interaction Database | BCR signaling pathway | ||||
| Atypical NF-kappaB pathway | |||||
| DNA-PK pathway in nonhomologous end joining | |||||
| Presenilin action in Notch and Wnt signaling | |||||
| Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
| E-cadherin signaling in the nascent adherens junction | |||||
| Lissencephaly gene (LIS1) in neuronal migration and development | |||||
| PDGFR-alpha signaling pathway | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| Alpha-synuclein signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.